Search

(Bloomberg) -- Germany's airports will come to a near standstill on Friday, adding to a week of chaos after snapped fiber cables grounded Deutsche Lufthansa AG's fleet. Workers had accidentally drilled through four cables buried some 16 feet below ground in a suburb close to the Frankfurt airport, bringing down the carrier's IT systems and grounding hundreds of flights worldwide. [Extracted from the article]

(Bloomberg) -- Germany's two largest airports warned of widespread halts to passenger flights on Friday after a union representing ground staff called for a one-day strike. German labor union Verdi has called for warning strikes at the nation's major airports on Friday to underline demands for wage increases. [Extracted from the article]

(Bloomberg) -- Germany's two largest airports are expected to halt passenger flights Friday after a union representing ground staff called for a one-day strike. German labor union Verdi has called for warning strikes at the nation's major airports on Friday to underline demands for wage increases. [Extracted from the article]

(Bloomberg) -- Chancellor Olaf Scholz agreed with regional leaders to keep Germany's current pandemic restrictions in place to help tackle a record surge in infections while raising the possibility of relaxing some curbs once the wave subsides. By then, Germany will probably have reached the peak of the omicron wave, Scholz said. [Extracted from the article]

Germany reported a third consecutive daily record in new infections Friday, and the seven-day incidence rate per 100,000 people climbed above the previous peak reached at the end of November. (Bloomberg) -- Germany warned that letting Covid-19 spread uncontrollably would lead to otherwise avoidable deaths even if the omicron strain is less severe than previous variants of the virus. [Extracted from the article]

To help accelerate the inoculation campaign, Germany will soon begin administering protein-based Covid shots manufactured by Novavax Inc., Lauterbach said. (Bloomberg) -- The head of Germany's public-health institute warned that the omicron variant of Covid-19 could become dominant in the country in the next one to two weeks with potentially serious consequences for hospitals and other critical infrastructure. [Extracted from the article]

Germany Faces "Long Road Ahead" in Covid Battle, Expert Warns Germany's infection rate declined for three straight days this week before rising slightly again to 442.1 on Friday, a level Wieler described as "still much too high." (Bloomberg) -- Germany has a long battle ahead against the Covid-19 pandemic, a top health official warned on Friday, with pressure set to increase on intensive-care units even as infections show signs of peaking. [Extracted from the article]

(Bloomberg) -- Subscribe to Prognosis (Spotify) Subscribe to Prognosis (Apple Podcasts)Two biotech companies, Germany's BioNTech and the U.S.'s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.©2021 Bloomberg L.P.By Naomi KresgeReported by Author [Extracted from the article]

(Bloomberg) -- German health authorities warned that the wave of Covid-19 cases sweeping over the country threatens to swamp the health-care system if residents don't act quickly to reduce their contacts. Hospitals in the hardest-hit areas are already transferring patients elsewhere, and doctors say it will be increasingly necessary to make tough decisions about which patients should get priority. [Extracted from the article]

(Bloomberg) -- Germany will stop subsidizing lost wages for unvaccinated people who miss work due to Covid-19 quarantine, the latest in a series of increasingly strict tactics to prod people to get their shots. Assuming no new vaccine-resistant variant emerges, Germany could reach herd immunity by spring and can "return to normal", Spahn was quoted as saying in an interview with Augsburger Allgemeine newspaper. [Extracted from the article]

(Bloomberg) -- Germany cut its Covid-19 risk level to "high" from "very high" in the latest sign that the coronavirus pandemic is loosening its grip on Europe's largest economy. Germany has been easing restrictions as infections fall and vaccinations accelerate. [Extracted from the article]

(Bloomberg) -- Even as Germany's sluggish Covid-19 vaccine campaign has left politicians arguing about who's to blame, the first signs of success are starting to emerge. With priority given to seniors and nursing-home residents, the infection rate in people over the age of 80 has plummeted by about 80% since the start of the vaccine campaign in late December. [Extracted from the article]

The article discusses German residents of Polish nursing-home facilities. The high cost of elderly care in Germany has prompted a growing number of families to consider Poland as a destination for their aged loved ones. Details are presented about the circumstances of Ilona von Haldenwang, who chose for her mother a nursing facility in Poland whose owner says will soon have 50% German occupancy.

(Bloomberg) -- Chancellor Angela Merkel warned that Germany is in the midst of a third wave of coronavirus infections and should proceed carefully with reopening schools and businesses, putting a damper on discussions to loosen lockdown curbs. After Merkel shot down Spahn's plan in a cabinet meeting on Monday, she will now discuss it with state leaders on March 3. [Extracted from the article]

(Bloomberg) -- Just weeks ago, the European Union was clamoring for AstraZeneca Plc's Covid-19 vaccine. The EU vaccine campaign is already far behind that of the U.S. and U.K., and catching up will be impossible in the near term unless people are willing to take the 300 million shots the bloc ordered from AstraZeneca. [Extracted from the article]

(Bloomberg) -- BioNTech SE started production at a new Covid-19 vaccine factory in Germany, moving closer to its goal of boosting output in Europe by some 750 million doses a year. The Marburg factory is a key piece of a plan by BioNTech and Pfizer to boost production of their shot to 2 billion doses this year. [Extracted from the article]

(Bloomberg) -- A senior member of Angela Merkel's conservative bloc took a swipe at the chancellor's vaccine strategy, calling for Germany to purchase shots at the national level because the European Union is too slow. "Germany cannot wait for the big and slow tanker EU in such an essential matter", Dobrindt, the caucus leader for the CSU, told reporters in Berlin on Tuesday. [Extracted from the article]

(Bloomberg) -- Angela Merkel is starting to crack under the pressure of Germany's faltering coronavirus vaccine program. Merkel's former defense minister made it clear to the chancellor that Spahn's effort could overshadow Germany's EU presidency. [Extracted from the article]

(Bloomberg) -- Germany cast doubt on the effectiveness of AstraZeneca Plc's Covid-19 shot for the elderly in a move that could perpetuate the European Union's vaccine supply shortages. Separately, the German commission recommended a four- to six-week waiting period between the two doses of the mRNA vaccines already approved in Europe. [Extracted from the article]

(Bloomberg) -- Germany cast doubt on the effectiveness of AstraZeneca Plc's Covid-19 shot for the elderly in a move that could perpetuate the European Union's vaccine supply shortages. While the vaccine appears to work as well as other vaccines, there was insufficient information on the shot's effectiveness for people over 65 years old, said the group, which evaluates vaccines for the German government. [Extracted from the article]

(Bloomberg) -- Germany cast doubt on the effectiveness of AstraZeneca Plc's Covid-19 shot for the elderly in a move that could perpetuate the European Union's vaccine supply shortages. While the vaccine appears to work as well as other vaccines, there was insufficient information on the shot's effectiveness for people over 65 years old, said the group, which evaluates vaccines for the German government. [Extracted from the article]

(Bloomberg) -- Chancellor Angela Merkel's government defended its decision to rely on the European Union to secure coronavirus vaccines, saying the approach is key for the region to recover and play a larger role in global affairs. While Spahn acknowledged that the rollout could have gone smoother, he said that if the EU didn't step up to support smaller countries, China or Russia could have. [Extracted from the article]

(Bloomberg) -- Chancellor Angela Merkel's government defended its decision to rely on the European Union to secure coronavirus vaccines, saying the approach is key for the region to recover and play a larger role in global affairs. Critics of Germany's strategy, including from within Chancellor Angela Merkel's ruling coalition, have asked why the government didn't secure more doses sooner. [Extracted from the article]

(Bloomberg) -- Chancellor Angela Merkel's voice briefly cracked as she appealed to Germans this week to rein in Christmas celebrations to protect grandma and grandpa from the coronavirus. On Friday, the country's contagion rate climbed to more than triple the target rate set by Merkel's government. When it became clear in mid-November that the infection rate was not coming down, Germany's federalist system -- in which states control health policy and schools -- became a major stumbling bloc for a clear response. [Extracted from the article]

(Bloomberg) -- Chancellor Angela Merkel's voice briefly cracked as she appealed to Germans this week to rein in Christmas celebrations to protect grandma and grandpa from the coronavirus. On Friday, the country's contagion rate climbed to more than triple the target rate set by Merkel's government. [Extracted from the article]

(Bloomberg) -- Germany is conducting direct negotiations with domestic Covid-19 vaccine developers to obtain more doses than would be allocated through the shared European Union plan, Health Minister Jens Spahn said. Among the other local vaccine makers, IDT isn't in talks with the EU, leaving Germany free to conduct its own negotiations, Spahn said. [Extracted from the article]

(Bloomberg) -- Germany is conducting direct negotiations with domestic Covid-19 vaccine developers to obtain more doses than would be allocated through the shared European Union plan, Health Minister Jens Spahn said on Wednesday. IDT isn't in talks with the EU, leaving Germany free to conduct its own negotiations, Spahn said. [Extracted from the article]

(Bloomberg) -- Germany's auto industry secured 5 billion euros ($5.9 billion) in government aid to help weather the coronavirus crisis and invest in the transition to electric cars. Carmakers and parts suppliers, which employ nearly 800,000 people in Germany, were spending heavily on electric cars before the pandemic hit. [Extracted from the article]

(Bloomberg) -- Germany's auto industry secured 5 billion euros ($5.9 billion) in government aid to help weather the coronavirus crisis and invest in the transition to electric cars. Carmakers and parts suppliers, which employ nearly 800,000 people in Germany, were spending heavily on electric cars before the pandemic hit. [Extracted from the article]

(Bloomberg) -- Germany's auto industry secured 5 billion euros ($5.9 billion) in government aid to help weather the coronavirus crisis and invest in the transition to electric cars. Carmakers and parts suppliers, which employ nearly 800,000 people in Germany, were spending heavily on electric cars before the pandemic hit. [Extracted from the article]

(Bloomberg) -- Chancellor Angela Merkel urged people to limit public and private gatherings, while pushing decisions on a road map for the coming months to next week as Germany struggles to stem the coronavirus spread. Two weeks into a partial shutdown -- which closed bars and restaurants but kept schools and most shops open -- Germany's contagion rates are still more than double the level authorities have determined to be manageable. [Extracted from the article]

(Bloomberg) -- Germany will buy a stake in CureVac AG, a player in the hotly contested race for a coronavirus vaccine, as governments jockey to ensure a supply of any successful pandemic shot. A CureVac investment marks its second deal after the landmark 9 billion-euro bailout of Deutsche Lufthansa AG, in which the government took a 20% stake in the struggling airline. [Extracted from the article]

(Bloomberg) -- Germany will buy a stake in CureVac AG, a player in the hotly contested race for a coronavirus vaccine, as governments jockey to ensure a supply of any successful pandemic shot. A CureVac investment marks its second deal after the landmark 9 billion-euro bailout of Deutsche Lufthansa AG, in which the government took a 20% stake in the struggling airline. [Extracted from the article]

(Bloomberg) -- Germany will buy a stake in CureVac AG, a player in the hotly contested race for a coronavirus vaccine, as governments jockey to ensure a supply of any successful pandemic shot. A CureVac investment marks its second deal after the landmark 9 billion-euro bailout of Deutsche Lufthansa AG, in which the government took a 20% stake in the struggling airline. [Extracted from the article]

(Bloomberg) -- Germany will buy a stake in CureVac AG, a player in the hotly contested race for a coronavirus vaccine, as governments jockey to ensure a supply of any successful pandemic shot. A CureVac investment marks its second deal after the landmark 9 billion-euro bailout of Deutsche Lufthansa AG, in which the government took a 20% stake in the struggling airline. [Extracted from the article]

(Bloomberg) -- Infections were never Joachim Lazarek's specialty. The Bavarian state government has promised 3,000 more personnel for health authorities to fight the virus, and across Germany the federal government says it's aiming for a team of five tracers per 20,000 inhabitants - almost 21,000 people nationwide. [Extracted from the article]

Germany has a powerful weapon in the battle to contain Covid-19: a wealth of private laboratories that are helping it test more than 50,000 people a day. The region has expanded its capacity to do 13,000 tests a day, with about 11,000 of those performed in private labs, Bavaria health minister Melanie Huml said Wednesday. [Extracted from the article]

Germany is just starting its fight against the new coronavirus as it tightens measures to contain the epidemic, the country's public health authority said. Some 32,705 patients have been confirmed with the virus in Germany, up from 28,942 yesterday, according to data from regional health authorities compiled by Bloomberg. [Extracted from the article]

(Bloomberg) -- As the coronavirus death toll surges across much of Europe, one country remains an anomaly. Despite more than 25,000 infections, the fifth-most in the world, Germany's mortality rate is only 0.4%, according to data compiled by Bloomberg from state health authorities. "We are only at the beginning of the epidemic", said Lothar Wieler, president of the Robert Koch Institute, Germany's public health authority. [Extracted from the article]

Germany has seen a trend toward the exponential growth in new cases flattening out and expects to see by Wednesday whether this is the case, according to the country's public health authority. "I am optimistic", Lothar Wieler, president of the Robert Koch Institute, said at a press conference earlier on Monday. [Extracted from the article]

(Bloomberg) -- Germany tightened border checks and urged the cancellation of major events as authorities across Europe took action to contain the coronavirus. A German government task force said late Friday that travelers from Italy, South Korea, Japan and Iran will need to disclose their health status upon arrival. [Extracted from the article]

(Bloomberg) -- Germany announced a slew of measures aimed at preventing the spread of the coronavirus by people coming into the country from affected areas. Train passengers entering Germany must also fill out forms declaring their health status, while rail operators will be required to reported symptomatic travelers to German authorities. [Extracted from the article]

(Bloomberg) -- Germany has asked about 1,000 people to stay at home as the country steps up measures to contain the spread of the coronavirus. A crisis task force in Germany will meet on Friday in Berlin to discuss next steps, including the possibility of canceling the ITB tourism trade fair. [Extracted from the article]

About 3,000 represent positions in areas such as information technology and other administrative functions, which includes some jobs being cut in the agriculture unit in connection with the Monsanto acquisition, said the people familiar with the situation. Though Baumann has said the reorganization has nothing to do with the glyphosate lawsuits, Bayer's legal travails have made it even more imperative for him to prove the deal is an operational success. [Extracted from the article]

The article discusses the increase in the birthrate in Germany as a result of immigration to the country, including in regard to people of Turkish descent in Germany, the percent of child births of foreign-born woman and the birth rates of second generation immigrants.

The article reports that drug maker Roche Holdings is offering money-back guarantees to insurance companies and hospitals in Germany on its Avastin cancer treatment. Roche will refund money in certain instances where patients' tumors have worsened following Avastin use. The policy exemplifies a trend in health-care toward linking insurance payments to medical outcomes.

The article discusses a law in Germany that governs the approval of new drugs. Pharmaceutical firms must demonstrate that a drug is both safe and more effective than existing alternatives. Special attention is paid to the efforts of drug company AstraZeneca to gain approval for its Brillique blood thinner.

The article focuses on the issue of sending old parents to affordable care homes in countries such as Poland from Germany. The families says that it is their best option to give a dignified old age for their parents and save money. The German population is expected to be among the world's oldest by 2050.